These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6539493)

  • 21. Estrogen and progesterone receptor assays in human breast cancer: sources of variation between laboratories.
    Borjesson BW; McGinley R; Foo TM; Smyth C; Toppila M; Compton P; Sarfaty GA
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):999-1004. PubMed ID: 3666003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of routine estrogen and progesterone assay: double labeling with 125-I-labeled estradiol and [3H]R5020.
    Grill HJ; Manz B; Pollow K
    Clin Chem; 1982 Mar; 28(3):552-3. PubMed ID: 7199978
    [No Abstract]   [Full Text] [Related]  

  • 23. Precision in estrogen and progesterone receptor assays. Results of the first CAP pilot survey.
    Oxley DK; Haven GT; Wittliff JL; Gilbo D
    Am J Clin Pathol; 1982 Oct; 78(4 Suppl):587-96. PubMed ID: 7137099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.
    Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S
    Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple extractions of hormone receptors from mixed human breast tumors.
    Chen YM; Rice RG; Vaughn CB
    Cancer Invest; 1985; 3(1):1-5. PubMed ID: 3971198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of dextran-coated charcoal and sucrose density gradient analyses of estrogen and progesterone receptors in human breast cancer.
    Anderson KM; Bonomi P; Marogil M; Hendrickson C; Economou S
    Cancer Res; 1980 Nov; 40(11):4127-32. PubMed ID: 6162545
    [No Abstract]   [Full Text] [Related]  

  • 27. Steroid receptors in breast angiosarcoma.
    Brentani MM; Pacheco MM; Oshima CT; Nagai MA; Lemos LB; Góes JC
    Cancer; 1983 Jun; 51(11):2105-11. PubMed ID: 6682350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progesterone receptors in breast cancer (author's transl)].
    Navarro Moreno MA; Pastor Ferrer MC; Carrera Font T; Planells Torres P; Bonnin Lafuente R; Rosel Soria P
    Med Clin (Barc); 1981 Sep; 77(4):158-61. PubMed ID: 7198174
    [No Abstract]   [Full Text] [Related]  

  • 29. Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment.
    Barnes DM; Ribeiro GG; Skinner LG
    Eur J Cancer (1965); 1977 Oct; 13(10):1133-43. PubMed ID: 923611
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of plasminogen activator activity and steroid receptors in human breast cancer.
    Thorsen T
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):129-32. PubMed ID: 7201390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiometric determination of E2 and Pg and quality control].
    Piffanelli A
    Pathologica; 1987; 79(1059-1060):27-32. PubMed ID: 3441408
    [No Abstract]   [Full Text] [Related]  

  • 32. [Stages of morphological differentiation of breast cancer and levels of estrogen and progestagen receptors].
    Lasota J; Padzik H; Woźniak L; Paszko Z
    Nowotwory; 1988; 38(1):9-15. PubMed ID: 3405790
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoglobulin G (IgG) levels in breast tumor cytosols.
    Winsten S; Tabachnick J; Young I
    Am J Clin Pathol; 1985 Mar; 83(3):364-6. PubMed ID: 3976571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the endogenous activation and inhibition of hormone receptor reaction.
    Chen YM; Vaughn CB
    Anticancer Res; 1984; 4(4-5):273-7. PubMed ID: 6486732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniques.
    Cappelletti V; Patriarca C; Granata G; Cattoretti G; Coradini D; Di Fronzo G; Horwitz K
    Breast Cancer Res Treat; 1989 Nov; 14(2):217-25. PubMed ID: 2690973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of microtitre plates for the routine assay of oestrogen and progesterone receptors in tissue extracts.
    Arrenbrecht S; Patakỳ F
    Scand J Clin Lab Invest; 1985 Feb; 45(1):55-60. PubMed ID: 3975566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical versus biochemical estrogen-receptor and progesterone-receptor analysis: correlation with histological parameters.
    Helle M; Helin M; Isola J; Helin H
    J Cancer Res Clin Oncol; 1989; 115(4):361-5. PubMed ID: 2760100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
    Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid receptor analyses of nine human breast cancer cell lines.
    Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL
    Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays.
    Koenders A; Thorpe SM
    Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1221-9. PubMed ID: 6684569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.